Home›Companies›Biotech & Pharma›Tasca Therapeutics

Tasca Therapeutics Corp

Updated Oct 27, 2026·Latest SEC filing Dec 1, 2025·Suggest an edit

About Tasca Therapeutics

Tasca Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $48,099,985 raised in one offering on Form D since November 2024. Its chief executive is Milenko Cicmil.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 13, 2024Nov 29, 2024amended Dec 1, 2025$48,099,985of $70.1M target9$5.3MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Tasca Therapeutics's Form D filed Dec 1, 2025.

David Fallace
David Fallace
Director
Also a director at Crosslink.
SL
MA
DK
Drew King
Executive officer
MC
Milenko Cicmil
President and CEO, director
XW
Xu Wu
Director

Sources

  1. SECTasca Therapeutics Corp Form D, filed Nov 29, 2024
  2. SECTasca Therapeutics Corp filing history